Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05498974

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

Sponsor: Second Xiangya Hospital of Central South University

View on ClinicalTrials.gov

Summary

The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

20000

Start Date

2022-01-01

Completion Date

2035-12-31

Last Updated

2022-08-12

Healthy Volunteers

No

Interventions

OTHER

Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center

Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center

Locations (11)

Gansu Provincial People's Hospital

Lanzhou, Gansu, China

Shenzhen Second People's Hospital

Shenzhen, Guangdong, China

Hainan General Hospital

Haikou, Hainan, China

the First Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

The First Affiliated Hospital of Henan University of Science and Technology

Luoyang, Henan, China

The Second Xiangya Hospital, Central South University

Changsha, Hunan, China

The First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

Heji Hospital Affiliated to Changzhi Medical College

Changzhi, Shanxi, China

The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

The First People's Hospital of Yunnan

Kunming, Yunnan, China

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China